Home › NCT07494812

Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials

Who can join

Ages 60 to 99 · All sexes

Inclusion Criteria:

* All patients will be adults aged 60 years or older with suspected iNPH who are being admitted to the hospital for the purpose of an LDT specifically to evaluate for benefit from shunt placement.

Exclusion Criteria:

* Patients who are under 18 years of age, pregnant, or are currently incarcerated will be excluded from participating in this study.

About the study

The intellidrop device is an FDA-approved system that automates safe, small volume of cerebral spinal fluid drainage with continuous pressure monitoring, reducing nursing workload and human error while improving patient mobility and comfort

What is being tested

• Intellidrop Automated CSF Drainage System (device)
• Intellidrop Automated CSF Drainage System (device)

Sponsor: University of Texas Southwestern Medical Center · Participants: 10 · Started: May 14, 2026

Contact the study team

• Padraig O'Suilleabhain, M.D. · Phone: 214-648-2943
• Maria Denbow, CCRP · Phone: 214-648-6719

Official record on ClinicalTrials.gov — NCT07494812

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.